New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
VANCOUVER, British Columbia, March 8, 2011 (GLOBE NEWSWIRE) -- Global Health Ventures Inc. (OTCBB:GHLV), a specialty pharmaceutical company focused on sublingual (under the tongue) drug delivery, is ...
The European Medicines Agency has recommended granting marketing authorization for a new hybrid formulation of buprenorphine as a substitution treatment of opioid drug dependence. Buprenorphine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results